Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Preguntas más frecuentes / Tipos de Cáncer
Todd Doyle, MD
Ultima Vez Modificado: 1 de noviembre del 2001
Dear OncoLink "Ask the Experts,"
Is there such a disease as Paget's Disease of the nipple? I?m asking only because there is a strange e-mail being circulated about it and I?ve never heard of it, though our family has a history of Paget's. I always thought it was a bone deformation disease that had nothing to do with cancer, though I could be wrong, but certainly didn?t think it had anything to do with the breast. Can you shed any light on this for me?
Thank you,
A.C.
Todd Doyle, MD, OncoLink Editorial Assistant, responds:
Dear AC:
Thank you very much for your interest and question regarding Paget's Disease of the nipple.
As you have alluded to, Paget's disease of bone (osteitis deformans) is a disease of uncertain etiology, which is characterized by excessive bone resorption accompanied by abnormal new bone formation. It is most often asymptomatic, but may involve pain, neurologic symptoms, increased calcium levels, fractures, or cardiovascular complications due to increased blood flow to abnormal bone. Treatment is not always required, but can range from NSAID's (aspirin, ibuprofen) to medicines to prevent bone resorption or even surgery to repair fractures.
Paget's disease of bone is medically unrelated to Paget's disease of the nipple, although it shares the same name. Paget's disease of the nipple is a rare form of breast cancer comprising 1 to 4% of all breast tumors. It is characterized by skin changes involving the nipple which resemble eczema. The relationship between the changes seen in the nipple and underlying breast cancer remains a matter of controversy. Many feel that the nipple involvement is secondary to migration of cells from an underlying cancer while others feel it is a separate process originating in the epidermis (superficial skin layer of the nipple). In 45% of cases, there is an associated palpable breast mass in the underlying breast while in most of the rest there are non invasive or invasive malignant cells. It is considered like other more common breast cancers when evaluating the extent of cancer. This work up includes a history and physical exam, mammogram, biopsy, and routine blood tests.
Traditionally, this disease has been treated by modified radical mastectomy. The rationale for this is the need to sacrifice the nipple and areola with conservation surgery anyway. Also, there is frequent, diffuse involvement of the ducts below the nipple, and frequent involvement with cancer at large distances from the nipple which may make conservation surgery more risky. In patients without a palpable mass and no evidence of tumor on mammography or disease confined to the subareolar area or nipple-areolar complex, it has been shown that excisional biopsy followed by radiation therapy to the whole breast is an acceptable alternative to mastectomy (which is reserved for local recurrences). Local recurrence rates and survival are similar to those seen with more common types of breast cancer when comparisons are made between similar stages (size of tumor and degree of spread).
Although breast cancer and Paget's disease of the nipple are not related to Paget's disease of bone, one important point remains. Approximately 1% of patients with Paget's disease of the bone develop a primary bone sarcoma in an area of their disease. This is a malignant tumor of the bone with an aggressive local growth pattern and a tendency to spread to distant sites. Most patients present with increasing pain in a localized area. Diagnosis can most often be made with plain x-rays and confirmed with a biopsy.
The following are some references for more information on Paget's disease of the nipple:
As an oncologist, Dr. Giantonio provides care for many patients at the end of life, which he describes as a privilege and rewarding. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

